Humana, NYSE Euronext: S&P Laggards
NEW YORK (TheStreet) - Humana (HUM) and NYSE Euronext (NYX) were among the worst-performing stocks in the S&P 500 on Monday.
The S&P 500 dropped 5.45 points, or 0.39%, on Monday to close at 1,397.91. The decline broke a four-day winning streak for the index, which finished April down 0.8%.
 |
Shares of Humana fell 8.1% on Monday at $80.68. The health care company reported first-quarter earnings of $248 million, or $1.49 a share, down from year-earlier earnings of $315 million, or $1.86 a share. Analysts anticipated earnings of $1.52 a share.
Humana also raised its full-year 2012 outlook to earnings of $7.55 to $7.75 a share from a prior range of $7.50 to $7.70 a share. Analysts are currently expecting earnings of $7.99 a share.
Humana shares trade at a forward price-to-earnings ratio of 9.04X; the average for health care providers is 17.17X. For comparison, WellPoint (WLP) has a lower forward P/E of 7.94X. Thirteen of the 21 analysts who cover Humana rate it at buy; eight analysts give the stock a hold rating. The stock has now fallen 7.91% year to date.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
